These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30896095)

  • 1. Retention Time of Four Common Poisons （Drugs） by GC-MS Qualitative Analysis.
    Liu SD; Min T; Wang M; Zhang DM
    Fa Yi Xue Za Zhi; 2018 Jun; 34(6):595-600. PubMed ID: 30896095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ion Abundance Ratios of Qualitative Analysis by GC-MS of 4 Common Drugs （Poisons.
    Liu SD; Min T; Xin GB; Zhang DM
    Fa Yi Xue Za Zhi; 2019 Dec; 35(6):687-694. PubMed ID: 31970955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention Time and Ion Abundance Ratio of 8 Common Drugs （Poisons） by LC-MS/MS Qualitative Analysis.
    Min T; Liu SD; Xin GB; Zhang DM
    Fa Yi Xue Za Zhi; 2020 Apr; 36(2):216-222. PubMed ID: 32530170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a high-throughput screening analysis for 288 drugs and poisons in human blood using Orbitrap technology with gas chromatography-high resolution accurate mass spectrometry.
    Pan M; Xiang P; Yu Z; Zhao Y; Yan H
    J Chromatogr A; 2019 Feb; 1587():209-226. PubMed ID: 30595433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an improved general unknown screening procedure using liquid chromatography-electrospray-mass spectrometry by comparison with gas chromatography and high-performance liquid-chromatography--diode array detection.
    Saint-Marcoux F; Lachâtre G; Marquet P
    J Am Soc Mass Spectrom; 2003 Jan; 14(1):14-22. PubMed ID: 12504330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid screening procedure for drugs and poisons in gastric contents by direct injection-HPLC analysis.
    Politi L; Groppi A; Polettini A; Montagna M
    Forensic Sci Int; 2004 May; 141(2-3):115-20. PubMed ID: 15062949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic toxicological analysis of drugs and poisons in biosamples by hyphenated chromatographic and spectroscopic techniques.
    Polettini A
    J Chromatogr B Biomed Sci Appl; 1999 Oct; 733(1-2):47-63. PubMed ID: 10572974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening procedure for detection of non-steroidal anti-inflammatory drugs and their metabolites in urine as part of a systematic toxicological analysis procedure for acidic drugs and poisons by gas chromatography-mass spectrometry after extractive methylation.
    Maurer HH; Tauvel FX; Kraemer T
    J Anal Toxicol; 2001; 25(4):237-44. PubMed ID: 11386636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass Spectrometry Applications for Toxicology.
    Mbughuni MM; Jannetto PJ; Langman LJ
    EJIFCC; 2016 Dec; 27(4):272-287. PubMed ID: 28149262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for basic drugs in 2-mL urine samples by dual-plate overpressured layer chromatography and comparison with gas chromatography-mass spectrometry.
    Pelander A; Ojanperä I; Sistonen J; Rasanen I; Vuori E
    J Anal Toxicol; 2003; 27(4):226-32. PubMed ID: 12820745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Position of chromatographic techniques in screening for detection of drugs or poisons in clinical and forensic toxicology and/or doping control.
    Maurer HH
    Clin Chem Lab Med; 2004; 42(11):1310-24. PubMed ID: 15576292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of four benzodiazepine residues in pork using multiwalled carbon nanotube solid-phase extraction and gas chromatography-mass spectrometry.
    Wang L; Zhao H; Qiu Y; Zhou Z
    J Chromatogr A; 2006 Dec; 1136(1):99-105. PubMed ID: 17054968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How can analytical diagnostics in clinical toxicology be successfully performed today?
    Maurer HH
    Ther Drug Monit; 2012 Oct; 34(5):561-4. PubMed ID: 22972537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry (GC x GC-TOFMS) for drug screening and confirmation.
    Song SM; Marriott P; Kotsos A; Drummer OH; Wynne P
    Forensic Sci Int; 2004 Jul; 143(2-3):87-101. PubMed ID: 15240028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Confirming Indicators of Qualitative Results by Chromatography-mass Spectrometry in Biological Samples].
    Liu SD; Zhang DM; Zhang W; Zhang WF
    Fa Yi Xue Za Zhi; 2017 Apr; 33(2):181-188. PubMed ID: 29231028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of estazolam, alprazolam and triazolam in human urine by LC/MSn].
    Gu JK; Xia R; Zhong DF; Sun L
    Yao Xue Xue Bao; 2002 Feb; 37(2):138-40. PubMed ID: 12579961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyphenated mass spectrometric techniques-indispensable tools in clinical and forensic toxicology and in doping control.
    Maurer HH
    J Mass Spectrom; 2006 Nov; 41(11):1399-413. PubMed ID: 17051522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of suvorexant in urine using gas chromatography/mass spectrometry.
    Carson M; Kerrigan S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():289-294. PubMed ID: 27825624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trace analysis for drugs and poisons in human tissues].
    Nagata T; Fukui Y; Kojima T; Yamada T; Suzuki O; Takahama K; Tsunenari S; Komura S; Takatori T; Kageura M
    Nihon Hoigaku Zasshi; 1992 Jun; 46(3):212-24. PubMed ID: 1405014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.